NAIROBI (Reuters) – Germany’s Bayer (OTC:) will contract a 3rd get together to distribute its pharmaceutical merchandise in 4 African markets together with Kenya, it mentioned, including that the impression on jobs can be minimal.
The corporate, which has 200 staff within the area, mentioned the transfer that targets Kenya, Ethiopia, Nigeria and Ghana, is not going to impression its crop science division, which makes up 90% of the enterprise.
Bayer will hand over the warehousing, distribution and gross sales illustration of the medicines enterprise, together with for oncology and ophthalmology, to an unidentified third firm starting in Could, it mentioned.
The corporate didn’t say what number of jobs could be affected, saying the method of figuring out these roles was ongoing.
The transfer mirrors that of Britain’s GSK, which mentioned in late 2022 it might swap to a third-party distribution mannequin for its medicines and vaccines in Kenya, and shut down its industrial organisation within the East African nation.